| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3013839 | Revista Española de Cardiología | 2008 | 12 Pages |
Abstract
Preventive treatment of FH with atorvastatin was cost-effective. The greatest costeffectiveness was obtained with atorvastatin monotherapy, 80 mg. The addition of ezetimibe could produce further benefits at an acceptable incremental cost.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Rodrigo Alonso, Jaime Fernández de Bobadilla, Ignacio Méndez, Pablo Lázaro, Nelva Mata, Pedro Mata,